Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Invest Ophthalmol Vis Sci ; 51(11): 5796-803, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20505203

RESUMEN

PURPOSE: Caspofungin is a synthetic echinocandin antifungal agent that inhibits the synthesis of ß(1,3)-D-glucan, an essential component of the cell wall of susceptible Aspergillus and Candida species. In this study, retinal toxicity was determined after intravitreal injection of caspofungin in a mouse model to assess its safety profile for the treatment of fungal endophthalmitis. METHODS: Caspofungin acetate was injected intravitreally in the left eyes of male C57BL/6 mice, with final vitreal concentrations corresponding to 0.41, 1.2, 2.5, 4.1, and 41 µM (five mice per cohort). A total of 25 age-matched male C57BL/6 mice injected with balanced salt solution were used as control subjects (five for each of the five different caspofungin acetate concentrations). Electroretinograms (ERGs) were recorded 7 weeks after the injections, and the injected eyes were examined histologically. RESULTS: Mice injected with caspofungin at vitreal concentrations from 0.41 to 4.1 µM did not have significant alterations in their ERG waveforms, and their retinas had no detectable morphologic changes or loss of cells. At the vitreal concentration of 41 µM, caspofungin reduced the amplitudes of the a-waves, b-waves, and scotopic threshold responses of the ERG and also produced a decrease in the number of cells in the ganglion cell layer. CONCLUSIONS: Caspofungin is a safe antifungal agent at vitreal concentrations of 0.41 to 4.1 µM in mice and consequently shows promise for the treatment of fungal endophthalmitis in humans. Much higher doses produce toxicity and should not be used.


Asunto(s)
Antifúngicos/toxicidad , Equinocandinas/toxicidad , Retina/efectos de los fármacos , Animales , Caspofungina , Evaluación Preclínica de Medicamentos , Electrorretinografía/efectos de los fármacos , Inyecciones Intravítreas , Lipopéptidos , Masculino , Ratones , Ratones Endogámicos C57BL , Retina/patología , Células Ganglionares de la Retina/efectos de los fármacos
2.
J Biomed Opt ; 14(3): 034048, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19566340

RESUMEN

The Nikon C1 confocal laser scanning microscope is a relatively inexpensive and user-friendly instrument. We describe a straightforward method to convert the C1 for multiphoton microscopy utilizing direct coupling of a femtosecond near-infrared laser into the scan head and fiber optic transmission of emission light to the three-channel detector box. Our adapted system can be rapidly switched between confocal and multiphoton mode, requires no modification to the original system, and uses only a few custom-made parts. The entire system, including scan mirrors and detector box, remain under the control of the user-friendly Nikon EZ-C1 software without modification.


Asunto(s)
Microscopía Confocal/instrumentación , Microscopía de Fluorescencia por Excitación Multifotónica/instrumentación , Animales , Diseño de Equipo , Proteínas Fluorescentes Verdes/biosíntesis , Proteínas Fluorescentes Verdes/química , Proteínas Fluorescentes Verdes/genética , Humanos , Procesamiento de Imagen Asistido por Computador/instrumentación , Procesamiento de Imagen Asistido por Computador/métodos , Ratones , Ratones Transgénicos , Microscopía Confocal/métodos , Microscopía de Fluorescencia por Excitación Multifotónica/métodos , Neuronas , Fibras Ópticas , Polen/ultraestructura , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Retina/citología , Retina/metabolismo , Rodopsina/biosíntesis , Rodopsina/química , Rodopsina/genética
3.
Am J Hum Genet ; 81(3): 438-53, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17701891

RESUMEN

Mutations in myelin genes cause inherited peripheral neuropathies that range in severity from adult-onset Charcot-Marie-Tooth disease type 1 to childhood-onset Dejerine-Sottas neuropathy and congenital hypomyelinating neuropathy. Many myelin gene mutants that cause severe disease, such as those in the myelin protein zero gene (MPZ) and the peripheral myelin protein 22 gene (PMP22), appear to make aberrant proteins that accumulate primarily within the endoplasmic reticulum (ER), resulting in Schwann cell death by apoptosis and, subsequently, peripheral neuropathy. We previously showed that curcumin supplementation could abrogate ER retention and aggregation-induced apoptosis associated with neuropathy-causing MPZ mutants. We now show reduced apoptosis after curcumin treatment of cells in tissue culture that express PMP22 mutants. Furthermore, we demonstrate that oral administration of curcumin partially mitigates the severe neuropathy phenotype of the Trembler-J mouse model in a dose-dependent manner. Administration of curcumin significantly decreases the percentage of apoptotic Schwann cells and results in increased number and size of myelinated axons in sciatic nerves, leading to improved motor performance. Our findings indicate that curcumin treatment is sufficient to relieve the toxic effect of mutant aggregation-induced apoptosis and improves the neuropathologic phenotype in an animal model of human neuropathy, suggesting a potential therapeutic role in selected forms of inherited peripheral neuropathies.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Curcumina/uso terapéutico , Neuropatía Hereditaria Motora y Sensorial/tratamiento farmacológico , Proteínas de la Mielina/genética , Células de Schwann/efectos de los fármacos , Administración Oral , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Apoptosis/efectos de los fármacos , Curcumina/administración & dosificación , Modelos Animales de Enfermedad , Células HeLa , Neuropatía Hereditaria Motora y Sensorial/genética , Neuropatía Hereditaria Motora y Sensorial/patología , Humanos , Ratones , Ratones Mutantes , Nervio Ciático/efectos de los fármacos , Nervio Ciático/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA